Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
3.660
+0.160 (4.57%)
At close: Jun 26, 2026, 4:00 PM EDT
4.000
+0.340 (9.29%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Larimar Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Larimar Therapeutics stock have an average target of 14.6, with a low estimate of 9.00 and a high estimate of 25. The average target predicts an increase of 298.91% from the current stock price of 3.66.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 27, 2026.
Analyst Ratings
The average analyst rating for Larimar Therapeutics stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 9 | 10 | 10 | 10 | 8 |
| Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 10 | 11 | 11 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Initiates $9 | Buy | Initiates | $9 | +145.90% | May 27, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | May 18, 2026 |
| Wedbush | Wedbush | Buy Maintains $12 | Buy | Maintains | $12 | +227.87% | May 18, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $25 | Buy | Reiterates | $25 | +583.06% | May 15, 2026 |
| Citi | Citi | Buy Reiterates $14 | Buy | Reiterates | $14 | +282.51% | Mar 20, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
58.30M
EPS This Year
-1.61
from -2.27
EPS Next Year
-1.17
from -1.61
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 191.3M | |
| Avg | n/a | 58.3M | |
| Low | n/a | 4.6M |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | 620.4% |
| Avg | - | 161.5% |
| Low | - | -29.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.43 | -0.16 | |
| Avg | -1.61 | -1.17 | |
| Low | -1.82 | -2.35 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.